Akito Hirakata

3.8k citations
140 papers · 2.4k indexed · h-index 27

Akito Hirakata

133 papers receiving 2.3k citations

Peers

Akito Hirakata
Comparison fields: 5 of 84
  • Ophthalmology 2.1k
  • Radiology, Nuclear Medicine and Imaging 1.7k
  • Neurology 369
  • Molecular Biology 419
  • Cancer Research 60
Replace Hidetaka Noma with:
Hidetaka Noma Japan
Farzin Forooghian Canada
Paolo Carpineto Italy
Young Suk Yu South Korea
Christoph W. Spraul Germany
Ayala Pollack Israel
H. Michael Lambert United States
Eun Ji Lee South Korea
Patricio G. Schlottmann United Kingdom
Giulio Barteselli United States
Akito Hirakata relative to Hidetaka Noma Japan Hidetaka Noma's profile →
Citations per field
00.5×1.5×
Hidetaka Noma · 1×
Citations per year

Countries citing papers authored by Akito Hirakata

Since Specialization
Citations

This map shows the geographic impact of Akito Hirakata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akito Hirakata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akito Hirakata more than expected).

Fields of papers citing papers by Akito Hirakata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akito Hirakata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akito Hirakata. The network helps show where Akito Hirakata may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Akito Hirakata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Akito Hirakata Line = papers co-authored together Akito Hirakata links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20234
2 20230
3 20211
4 20200
5 20201
6 201924
7
Endophthalmitis Rates of Ranibizumab in Pre-Filled Syringes Compared to Vials
20181
8 20171
9 201618
10 201527
11 201512
12 201526
13 201333
14 20124
15 201291
16 20094
17 200819
18 200629
19 200527
20
ABCA4 gene mutations in Japanese patients with Stargardt disease and retinitis pigmentosa.
200253

About Akito Hirakata

Akito Hirakata is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 140 papers that have together received 2.4k indexed citations. Recurring topics across this work include Retinal and Macular Surgery (78 papers), Intraocular Surgery and Lenses (61 papers), Retinal Diseases and Treatments (51 papers), Glaucoma and retinal disorders (50 papers), Vascular Malformations Diagnosis and Treatment (19 papers), Corneal surgery and disorders (13 papers), Ocular Diseases and Behçet’s Syndrome (13 papers) and Retinal Development and Disorders (13 papers). The work is most often cited by research in Ophthalmology (2.1k citations), Radiology, Nuclear Medicine and Imaging (1.7k citations) and Neurology (369 citations). Akito Hirakata has collaborated with scholars based in Japan, United States and Hungary. Frequent co-authors include Makoto Inoue, Tetsuo Hida, Yuji Itoh, Annabelle A. Okada, Tosho Rii, Kazunari Hirota, Tomoyuki Hiraoka, Hiroshi Keino, Takashi Koto and Tatsuro Ishibashi.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026